A carregar...
Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy
BACKGROUND: Buprenorphine is an FDA-approved maintenance therapy for opioid use disorders and is increasingly being used in pregnant women with opioid use disorders as an alternative to methadone. Dosing of buprenorphine in pregnant women is based on the regimen recommended for non-pregnant females...
Na minha lista:
| Publicado no: | Am J Obstet Gynecol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5245872/ https://ncbi.nlm.nih.gov/pubmed/27687214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2016.09.095 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|